ATM Inhibitor-1
ATM Inhibitor-1 is a highly potent, selective and orally active ATM inhibitor, with an IC50 of 0.7 nM, shows weak activity against mTOR (IC50, 21 μM), DNAPK (IC50, 2.8 μM), PI3Kα (IC50, 3.8 μM), PI3Kβ (IC50, 10.3 μM), PI3Kγ (IC50, 3 μM) and PI3Kδ (IC50, 0.73 μM). ATM Inhibitor-1 exhibits anti-tumor activity.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2135639-94-8
- 화학식: C27H36N6O3
- 분자량:492.61
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
ATM 0.7 nM (IC50) |
ATM 2.8 nM (IC50, Cellular assay) |
PI3Kδ 0.73 μM (IC50) |
PI3Kγ 3 μM (IC50) |
PI3Kα 3.8 μM (IC50) |
PI3Kβ 10.3 μM (IC50) |
DNAPK 2.8 μM (IC50) |
mTOR 21 μM (IC50) |
ATM Inhibitor-1 (Compound 21) is a highly potent, selective and orally active ATM Inhibitor, with an IC50 of 0.7 nM, shows weak activity against mTOR (IC50, 21 μM), DNAPK (IC50, 2.8 μM), PI3Kα (IC50, 3.8 μM), PI3Kβ (IC50, 10.3 μM), PI3Kγ (IC50, 3 μM) and PI3Kδ (IC50, 0.73 μM)[1].
In cellular assays, ATM Inhibitor-1 exhibits IC50s of 2.8 nM, >30 μM and >19 μM for ATM, ATR/PI3Kα and PI3Kβ/mTOR, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SW620 mice model[1]
-
Dosage:50 mg/kg
-
Administration:P.O., once daily for 3 days every week starting 24 h post-irinotecan dosing, 21 days
-
Result:Inhibited the growth of tumor combined with 50 mg/kg irinotecan in SW620 mice model.
Chemical Information
-
CAS No. 2135639-94-8
-
분자량 492.61
-
화학식 C27H36N6O3
-
SMILES
C[C@@H](C1CCOCC1)NC2=C(C(NC)=O)N=NC3=CC=C(C4=CC=C(OCCCN(C)C)N=C4)C=C32
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)